Announcement
18 May 2021
In May 2021, the Canadian government announced providing approximately CAD 200 million to Resilience Biotechnologies Inc. to support its investment in increasing its manufacturing capacity of fill-finish vaccines and therapeutics on a commercial scale.
Source
Number of interventions
1
1 certainly harmful
0 likely harmful
0 liberalising
Implementation date
18 May 2021
Revocation date:
No revocation date
On 18 May 2021, the government of Canada announced providing approximately CAD 200 million (USD 165 milliion) to Resilience Biotechnologies Inc. to help the company increase its manufacturing and f...
31 Mar 2021
Canada: Sanofi makes a CAD 925 million investment in Canada’s biomanufacturing sector with government support
16 Mar 2021
Canada: Government provides funding to a Canadian biotechnology company through Phase II clinical trials of a therapeutic candidate against COVID-19
16 Mar 2021
Canada: KABS Laboratories secure CAD 52.2 million from the Strategic Innovation Fund
16 Mar 2021
Canada: Novocol Pharma secures funding from the Canadian government
02 Feb 2021
Canada: Government provides funding for the production of ribonucleic acid vaccines and future genetic medicines in Canada
02 Feb 2021
Canada: Government provided funding for the advancement of monoclonal antibody therapy for acute respiratory distress syndrome (COVID-19)
23 Oct 2020
Canada: Medicago Inc. secures CAD 173 million from the government for the development of Coronavirus Virus-Like Particle (VLP) vaccine
22 Oct 2020
Canada: Precision NanoSystems secures funding from the government to develop a COVID-19 mRNA vaccine
05 Aug 2020
Canada: Canadian governments supports the clinical trials of Variation Biotechnologies’ COVID-19 vaccine candidate
03 May 2020
Canada: Government invests in antibody discovery technology to fight against COVID-19
23 Mar 2020
Canada: Government allocates CAD 792 million for the development and production of medical countermeasures to COVID-19
See all
This state act is not part of any Thread yet.